An FDA Panel Spread Misinformation About SSRI Use In Pregnancy, Alarming Doctors

Nearly 20% of pregnant women and new mothers in the U.S. experience anxiety or depression, and 6–8% are prescribed antidepressants known as Selective Serotonin Reuptake Inhibitors (SSRIs).

Although most healthcare professionals regard SSRIs as generally safe, a recent expert panel convened by the U.S. Food and Drug Administration questioned their safety.

These remarks have drawn strong criticism from several leading medical organizations. Read More